Dr. McKenna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles St
Boston, MA 02114Phone+1 617-573-4458
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Otolaryngology - Head and Neck Surgery, 1984 - 1988
- Huntington Memorial HospitalInternship, Transitional Year, 1982 - 1983
- Keck School of Medicine of the University of Southern CaliforniaClass of 1982
Certifications & Licensure
- CA State Medical License 1983 - Present
- MA State Medical License 1989 - 2025
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
- American Board of Otolaryngology - Head and Neck Surgery Neurotology
Awards, Honors, & Recognition
- Vegas Seven Castle Connolly, 2014
- America's Top Doctors Castle Connolly, 2004-2014
- Boston Magazine Castle Connolly, 2008-2013
- Join now to see all
Publications & Presentations
PubMed
- 80 citationsS-glutathionylation of troponin I (fast) increases contractile apparatus Ca2+ sensitivity in fast-twitch muscle fibres of rats and humans.Janelle P. Mollica, Travis L. Dutka, Troy L. Merry, Cedric R. Lamboley, Glenn K. McConell
The Journal of Physiology. 2012-03-01 - 23 citationsActivation of skeletal muscle calpain-3 by eccentric exercise in humans does not result in its translocation to the nucleus or cytosol.Robyn M. Murphy, Kristian Vissing, Heidy Latchman, Cedric R. Lamboley, Michael J. McKenna
Journal of Applied Physiology. 2011-11-01 - 54 citationsCalpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exerciseRobyn M. Murphy, Craig A. Goodman, Michael J. McKenna, Jason A. Bennie, Murray J. Leikis
Journal of Applied Physiology. 2007-09-01
Press Mentions
- Akouos Discloses Lead Program, AK-OTOF, a Potential Gene Therapy for Sensorineural Hearing LossSeptember 12th, 2019
- Akouos Announces Executive Leadership Team AppointmentsSeptember 3rd, 2019
- Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve HearingAugust 7th, 2018
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: